Paris, France and Camberley, UK – 13 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 12 November 2020, Jean-Pierre Crinelli, a Non-Executive Director of the Company, purchased 1,541 ordinary shares of €1/15 each in the Company at a price of
Visit PageNews and Events
Participations des Administrateurs / PERD
Paris, France et Camberley, Royaume-Uni – 12 novembre 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce avoir été informée, le 11 novembre 2020, de l’achat par Graham Mullis, Directeur Général de la société, de 60 875 actions ordinaires de la société d’une valeur nominale de 1/15
Visit PageDirector/PDMR Shareholding
Paris, France and Camberley, UK – 12 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 11 November 2020, Graham Mullis, Chief Executive of the Company, acquired 60,875 ordinary shares of €1/15 each in the Company at a price of £8.17
Visit Page